NCT05725759View on ClinicalTrials.gov

Rehabilitation in SOD1 ALS Treated With Tofersen

Enrolling by invitationOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Amyotrophic Lateral SclerosisLou Gehrig DiseaseFamilial Amyotrophic Lateral SclerosisMotor Neuron DiseaseMotor Neuron Disease, Familial
Interventions
BEHAVIORAL

Rehabilitation

Particapants currently receiving tofersen treatment will be referred to outpatient physical and/or occupational therapy.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER